SCHEMBL1987660

SCHEMBL1987660

Cc1cccc(C(=O)NC2CC2)c1C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 2/20 0.64
▸ TAS1R1 Q7RTX1 2/20 0.64
▸ TAS1R2 Q8TE23 2/20 0.64
▸ NPC1 O15118 2/20 0.64
▸ RAB9A P51151 2/20 0.64
▸ P2RX7 Q99572 1/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ GLA P06280 1/20 0.52
▸ ALDH1A1 P00352 4/20 0.51
▸ HPGD P15428 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ POLB P06746 2/20 0.51
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ DRD4 P21917 1/20 0.48
▸ ALOX15 P16050 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14688259 0.94 TAS1R3 (0.62) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL22123764 0.89 TAS1R3 (0.57) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL20477095 0.89 SMN1; SMN2 (0.57) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL20477092 0.88 TAS1R3 (0.56) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL457993 0.86 NPC1 (0.84) NPC1RAB9AP2RX7SMN1; SMN2GLA
SCHEMBL29062256 0.84 TAS1R3 (0.54) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL28785590 0.84 TAS1R3 (0.54) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL695642 0.83 P2RX7 (0.71) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL19155146 0.83 NPC1 (0.60) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL3172457 0.83 TAS1R3 (0.59) TAS1R3TAS1R1TAS1R2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501830-B1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2011-10-05 — — EP claimed
EP-1846407-B1 7-{4-[2-(2,6-DICHLORO-4-METHYLPHENOXY)ETHOXY]PHENYL}-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE-6-CARBOXYLIC ACID CYCLOPROPYL-(2,3-DIMETHYLBENZYL)AMIDE AS INHIBITOR OF RENIN FOR THE TREATMENT OF HYPERTENSION. ACTELION PHARMACEUTICALS LTD (CH) 2011-06-29 — — EP claimed
EP-1786814-B1 BICYCLONONENE DERIVATIVES AS RENIN INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2010-03-31 — — EP claimed
EP-1620403-B1 NOVEL 3,4-DISUBSTITUTED 1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2007-11-28 — — EP claimed
WO-2007049224-A1 NOVEL HEXAHYDRO- OR OCTAHYDRO-CYCLOPENTA[C]PYRROLE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2007-05-03 — — WO claimed
WO-2013084241-A1 COMPOUNDS AS INHIBITORS OF RENIN CADILA HEALTHCARE LIMITED (IN) 2013-06-13 — — WO disclosed
WO-2012085935-A2 COMPOUNDS AS INHIBITORS OF RENIN CADILA HEALTHCARE LIMITED (IN) 2012-06-28 — — WO disclosed
WO-2007049224-A1 NOVEL HEXAHYDRO- OR OCTAHYDRO-CYCLOPENTA[C]PYRROLE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2007-05-03 — — WO disclosed
Send feedback